StreetInsider.com News Articles

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders

Mon, 21 Apr 2025 16:05:00 -0400

Believes Company’s Misguided Acquisition Strategy is Destroying Value and Preventing Dynavax from Maximizing the Opportunities of Heplisav for Shareholders and Patients

In Deep Track’s View, Properly Focusing on Heplisav Could Result in More than $1 Billion in Cash Generation by 2030 – More than Dynavax’s Current Enterprise Value

Sees Shareholder Representation on Board as Necessary to Restore Investor Confidence in Dynavax and Prevent Strategic Blunders

Urges Shareholders to Vote FOR Deep Track’s Four Highly Qualified Director Nominees

GREENWICH, Conn.--(BUSINESS WIRE)-- Deep Track Capital, LP, (together with its affiliates, “Deep Track” or “we”), one of the largest shareholders

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders

Mon, 21 Apr 2025 16:05:00 -0400

Believes Company’s Misguided Acquisition Strategy is Destroying Value and Preventing Dynavax from Maximizing the Opportunities of Heplisav for Shareholders and Patients

In Deep Track’s View, Properly Focusing on Heplisav Could Result in More than $1 Billion in Cash Generation by 2030 – More than Dynavax’s Current Enterprise Value

Sees Shareholder Representation on Board as Necessary to Restore Investor Confidence in Dynavax and Prevent Strategic Blunders

Urges Shareholders to Vote FOR Deep Track’s Four Highly Qualified Director Nominees

GREENWICH, Conn.--(BUSINESS WIRE)-- Deep Track Capital, LP, (together with its affiliates, “Deep Track” or “we”), one of the largest shareholders

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders

Mon, 21 Apr 2025 16:05:00 -0400

Believes Company’s Misguided Acquisition Strategy is Destroying Value and Preventing Dynavax from Maximizing the Opportunities of Heplisav for Shareholders and Patients

In Deep Track’s View, Properly Focusing on Heplisav Could Result in More than $1 Billion in Cash Generation by 2030 – More than Dynavax’s Current Enterprise Value

Sees Shareholder Representation on Board as Necessary to Restore Investor Confidence in Dynavax and Prevent Strategic Blunders

Urges Shareholders to Vote FOR Deep Track’s Four Highly Qualified Director Nominees

GREENWICH, Conn.--(BUSINESS WIRE)-- Deep Track Capital, LP, (together with its affiliates, “Deep Track” or “we”), one of the largest shareholders

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders

Mon, 21 Apr 2025 16:05:00 -0400

Believes Company’s Misguided Acquisition Strategy is Destroying Value and Preventing Dynavax from Maximizing the Opportunities of Heplisav for Shareholders and Patients

In Deep Track’s View, Properly Focusing on Heplisav Could Result in More than $1 Billion in Cash Generation by 2030 – More than Dynavax’s Current Enterprise Value

Sees Shareholder Representation on Board as Necessary to Restore Investor Confidence in Dynavax and Prevent Strategic Blunders

Urges Shareholders to Vote FOR Deep Track’s Four Highly Qualified Director Nominees

GREENWICH, Conn.--(BUSINESS WIRE)-- Deep Track Capital, LP, (together with its affiliates, “Deep Track” or “we”), one of the largest shareholders

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders

Mon, 21 Apr 2025 16:05:00 -0400

Believes Company’s Misguided Acquisition Strategy is Destroying Value and Preventing Dynavax from Maximizing the Opportunities of Heplisav for Shareholders and Patients

In Deep Track’s View, Properly Focusing on Heplisav Could Result in More than $1 Billion in Cash Generation by 2030 – More than Dynavax’s Current Enterprise Value

Sees Shareholder Representation on Board as Necessary to Restore Investor Confidence in Dynavax and Prevent Strategic Blunders

Urges Shareholders to Vote FOR Deep Track’s Four Highly Qualified Director Nominees

GREENWICH, Conn.--(BUSINESS WIRE)-- Deep Track Capital, LP, (together with its affiliates, “Deep Track” or “we”), one of the largest shareholders

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders

Mon, 21 Apr 2025 16:05:00 -0400

Believes Company’s Misguided Acquisition Strategy is Destroying Value and Preventing Dynavax from Maximizing the Opportunities of Heplisav for Shareholders and Patients

In Deep Track’s View, Properly Focusing on Heplisav Could Result in More than $1 Billion in Cash Generation by 2030 – More than Dynavax’s Current Enterprise Value

Sees Shareholder Representation on Board as Necessary to Restore Investor Confidence in Dynavax and Prevent Strategic Blunders

Urges Shareholders to Vote FOR Deep Track’s Four Highly Qualified Director Nominees

GREENWICH, Conn.--(BUSINESS WIRE)-- Deep Track Capital, LP, (together with its affiliates, “Deep Track” or “we”), one of the largest shareholders

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders

Mon, 21 Apr 2025 16:05:00 -0400

Believes Company’s Misguided Acquisition Strategy is Destroying Value and Preventing Dynavax from Maximizing the Opportunities of Heplisav for Shareholders and Patients

In Deep Track’s View, Properly Focusing on Heplisav Could Result in More than $1 Billion in Cash Generation by 2030 – More than Dynavax’s Current Enterprise Value

Sees Shareholder Representation on Board as Necessary to Restore Investor Confidence in Dynavax and Prevent Strategic Blunders

Urges Shareholders to Vote FOR Deep Track’s Four Highly Qualified Director Nominees

GREENWICH, Conn.--(BUSINESS WIRE)-- Deep Track Capital, LP, (together with its affiliates, “Deep Track” or “we”), one of the largest shareholders

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders

Mon, 21 Apr 2025 16:05:00 -0400

Believes Company’s Misguided Acquisition Strategy is Destroying Value and Preventing Dynavax from Maximizing the Opportunities of Heplisav for Shareholders and Patients

In Deep Track’s View, Properly Focusing on Heplisav Could Result in More than $1 Billion in Cash Generation by 2030 – More than Dynavax’s Current Enterprise Value

Sees Shareholder Representation on Board as Necessary to Restore Investor Confidence in Dynavax and Prevent Strategic Blunders

Urges Shareholders to Vote FOR Deep Track’s Four Highly Qualified Director Nominees

GREENWICH, Conn.--(BUSINESS WIRE)-- Deep Track Capital, LP, (together with its affiliates, “Deep Track” or “we”), one of the largest shareholders

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders

Mon, 21 Apr 2025 16:05:00 -0400

Believes Company’s Misguided Acquisition Strategy is Destroying Value and Preventing Dynavax from Maximizing the Opportunities of Heplisav for Shareholders and Patients

In Deep Track’s View, Properly Focusing on Heplisav Could Result in More than $1 Billion in Cash Generation by 2030 – More than Dynavax’s Current Enterprise Value

Sees Shareholder Representation on Board as Necessary to Restore Investor Confidence in Dynavax and Prevent Strategic Blunders

Urges Shareholders to Vote FOR Deep Track’s Four Highly Qualified Director Nominees

GREENWICH, Conn.--(BUSINESS WIRE)-- Deep Track Capital, LP, (together with its affiliates, “Deep Track” or “we”), one of the largest shareholders

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders

Mon, 21 Apr 2025 16:05:00 -0400

Believes Company’s Misguided Acquisition Strategy is Destroying Value and Preventing Dynavax from Maximizing the Opportunities of Heplisav for Shareholders and Patients

In Deep Track’s View, Properly Focusing on Heplisav Could Result in More than $1 Billion in Cash Generation by 2030 – More than Dynavax’s Current Enterprise Value

Sees Shareholder Representation on Board as Necessary to Restore Investor Confidence in Dynavax and Prevent Strategic Blunders

Urges Shareholders to Vote FOR Deep Track’s Four Highly Qualified Director Nominees

GREENWICH, Conn.--(BUSINESS WIRE)-- Deep Track Capital, LP, (together with its affiliates, “Deep Track” or “we”), one of the largest shareholders

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders

Mon, 21 Apr 2025 16:05:00 -0400

Believes Company’s Misguided Acquisition Strategy is Destroying Value and Preventing Dynavax from Maximizing the Opportunities of Heplisav for Shareholders and Patients

In Deep Track’s View, Properly Focusing on Heplisav Could Result in More than $1 Billion in Cash Generation by 2030 – More than Dynavax’s Current Enterprise Value

Sees Shareholder Representation on Board as Necessary to Restore Investor Confidence in Dynavax and Prevent Strategic Blunders

Urges Shareholders to Vote FOR Deep Track’s Four Highly Qualified Director Nominees

GREENWICH, Conn.--(BUSINESS WIRE)-- Deep Track Capital, LP, (together with its affiliates, “Deep Track” or “we”), one of the largest shareholders

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders

Mon, 21 Apr 2025 16:05:00 -0400

Believes Company’s Misguided Acquisition Strategy is Destroying Value and Preventing Dynavax from Maximizing the Opportunities of Heplisav for Shareholders and Patients

In Deep Track’s View, Properly Focusing on Heplisav Could Result in More than $1 Billion in Cash Generation by 2030 – More than Dynavax’s Current Enterprise Value

Sees Shareholder Representation on Board as Necessary to Restore Investor Confidence in Dynavax and Prevent Strategic Blunders

Urges Shareholders to Vote FOR Deep Track’s Four Highly Qualified Director Nominees

GREENWICH, Conn.--(BUSINESS WIRE)-- Deep Track Capital, LP, (together with its affiliates, “Deep Track” or “we”), one of the largest shareholders

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders

Mon, 21 Apr 2025 16:05:00 -0400

Believes Company’s Misguided Acquisition Strategy is Destroying Value and Preventing Dynavax from Maximizing the Opportunities of Heplisav for Shareholders and Patients

In Deep Track’s View, Properly Focusing on Heplisav Could Result in More than $1 Billion in Cash Generation by 2030 – More than Dynavax’s Current Enterprise Value

Sees Shareholder Representation on Board as Necessary to Restore Investor Confidence in Dynavax and Prevent Strategic Blunders

Urges Shareholders to Vote FOR Deep Track’s Four Highly Qualified Director Nominees

GREENWICH, Conn.--(BUSINESS WIRE)-- Deep Track Capital, LP, (together with its affiliates, “Deep Track” or “we”), one of the largest shareholders

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders

Mon, 21 Apr 2025 16:05:00 -0400

Believes Company’s Misguided Acquisition Strategy is Destroying Value and Preventing Dynavax from Maximizing the Opportunities of Heplisav for Shareholders and Patients

In Deep Track’s View, Properly Focusing on Heplisav Could Result in More than $1 Billion in Cash Generation by 2030 – More than Dynavax’s Current Enterprise Value

Sees Shareholder Representation on Board as Necessary to Restore Investor Confidence in Dynavax and Prevent Strategic Blunders

Urges Shareholders to Vote FOR Deep Track’s Four Highly Qualified Director Nominees

GREENWICH, Conn.--(BUSINESS WIRE)-- Deep Track Capital, LP, (together with its affiliates, “Deep Track” or “we”), one of the largest shareholders

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders

Mon, 21 Apr 2025 16:05:00 -0400

Believes Company’s Misguided Acquisition Strategy is Destroying Value and Preventing Dynavax from Maximizing the Opportunities of Heplisav for Shareholders and Patients

In Deep Track’s View, Properly Focusing on Heplisav Could Result in More than $1 Billion in Cash Generation by 2030 – More than Dynavax’s Current Enterprise Value

Sees Shareholder Representation on Board as Necessary to Restore Investor Confidence in Dynavax and Prevent Strategic Blunders

Urges Shareholders to Vote FOR Deep Track’s Four Highly Qualified Director Nominees

GREENWICH, Conn.--(BUSINESS WIRE)-- Deep Track Capital, LP, (together with its affiliates, “Deep Track” or “we”), one of the largest shareholders

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders

Mon, 21 Apr 2025 16:05:00 -0400

Believes Company’s Misguided Acquisition Strategy is Destroying Value and Preventing Dynavax from Maximizing the Opportunities of Heplisav for Shareholders and Patients

In Deep Track’s View, Properly Focusing on Heplisav Could Result in More than $1 Billion in Cash Generation by 2030 – More than Dynavax’s Current Enterprise Value

Sees Shareholder Representation on Board as Necessary to Restore Investor Confidence in Dynavax and Prevent Strategic Blunders

Urges Shareholders to Vote FOR Deep Track’s Four Highly Qualified Director Nominees

GREENWICH, Conn.--(BUSINESS WIRE)-- Deep Track Capital, LP, (together with its affiliates, “Deep Track” or “we”), one of the largest shareholders

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders

Mon, 21 Apr 2025 16:05:00 -0400

Believes Company’s Misguided Acquisition Strategy is Destroying Value and Preventing Dynavax from Maximizing the Opportunities of Heplisav for Shareholders and Patients

In Deep Track’s View, Properly Focusing on Heplisav Could Result in More than $1 Billion in Cash Generation by 2030 – More than Dynavax’s Current Enterprise Value

Sees Shareholder Representation on Board as Necessary to Restore Investor Confidence in Dynavax and Prevent Strategic Blunders

Urges Shareholders to Vote FOR Deep Track’s Four Highly Qualified Director Nominees

GREENWICH, Conn.--(BUSINESS WIRE)-- Deep Track Capital, LP, (together with its affiliates, “Deep Track” or “we”), one of the largest shareholders

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders

Mon, 21 Apr 2025 16:05:00 -0400

Believes Company’s Misguided Acquisition Strategy is Destroying Value and Preventing Dynavax from Maximizing the Opportunities of Heplisav for Shareholders and Patients

In Deep Track’s View, Properly Focusing on Heplisav Could Result in More than $1 Billion in Cash Generation by 2030 – More than Dynavax’s Current Enterprise Value

Sees Shareholder Representation on Board as Necessary to Restore Investor Confidence in Dynavax and Prevent Strategic Blunders

Urges Shareholders to Vote FOR Deep Track’s Four Highly Qualified Director Nominees

GREENWICH, Conn.--(BUSINESS WIRE)-- Deep Track Capital, LP, (together with its affiliates, “Deep Track” or “we”), one of the largest shareholders

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders

Mon, 21 Apr 2025 16:05:00 -0400

Believes Company’s Misguided Acquisition Strategy is Destroying Value and Preventing Dynavax from Maximizing the Opportunities of Heplisav for Shareholders and Patients

In Deep Track’s View, Properly Focusing on Heplisav Could Result in More than $1 Billion in Cash Generation by 2030 – More than Dynavax’s Current Enterprise Value

Sees Shareholder Representation on Board as Necessary to Restore Investor Confidence in Dynavax and Prevent Strategic Blunders

Urges Shareholders to Vote FOR Deep Track’s Four Highly Qualified Director Nominees

GREENWICH, Conn.--(BUSINESS WIRE)-- Deep Track Capital, LP, (together with its affiliates, “Deep Track” or “we”), one of the largest shareholders

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders

Mon, 21 Apr 2025 16:05:00 -0400

Believes Company’s Misguided Acquisition Strategy is Destroying Value and Preventing Dynavax from Maximizing the Opportunities of Heplisav for Shareholders and Patients

In Deep Track’s View, Properly Focusing on Heplisav Could Result in More than $1 Billion in Cash Generation by 2030 – More than Dynavax’s Current Enterprise Value

Sees Shareholder Representation on Board as Necessary to Restore Investor Confidence in Dynavax and Prevent Strategic Blunders

Urges Shareholders to Vote FOR Deep Track’s Four Highly Qualified Director Nominees

GREENWICH, Conn.--(BUSINESS WIRE)-- Deep Track Capital, LP, (together with its affiliates, “Deep Track” or “we”), one of the largest shareholders

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders

Mon, 21 Apr 2025 16:05:00 -0400

Believes Company’s Misguided Acquisition Strategy is Destroying Value and Preventing Dynavax from Maximizing the Opportunities of Heplisav for Shareholders and Patients

In Deep Track’s View, Properly Focusing on Heplisav Could Result in More than $1 Billion in Cash Generation by 2030 – More than Dynavax’s Current Enterprise Value

Sees Shareholder Representation on Board as Necessary to Restore Investor Confidence in Dynavax and Prevent Strategic Blunders

Urges Shareholders to Vote FOR Deep Track’s Four Highly Qualified Director Nominees

GREENWICH, Conn.--(BUSINESS WIRE)-- Deep Track Capital, LP, (together with its affiliates, “Deep Track” or “we”), one of the largest shareholders

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders

Mon, 21 Apr 2025 16:05:00 -0400

Believes Company’s Misguided Acquisition Strategy is Destroying Value and Preventing Dynavax from Maximizing the Opportunities of Heplisav for Shareholders and Patients

In Deep Track’s View, Properly Focusing on Heplisav Could Result in More than $1 Billion in Cash Generation by 2030 – More than Dynavax’s Current Enterprise Value

Sees Shareholder Representation on Board as Necessary to Restore Investor Confidence in Dynavax and Prevent Strategic Blunders

Urges Shareholders to Vote FOR Deep Track’s Four Highly Qualified Director Nominees

GREENWICH, Conn.--(BUSINESS WIRE)-- Deep Track Capital, LP, (together with its affiliates, “Deep Track” or “we”), one of the largest shareholders

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders

Mon, 21 Apr 2025 16:05:00 -0400

Believes Company’s Misguided Acquisition Strategy is Destroying Value and Preventing Dynavax from Maximizing the Opportunities of Heplisav for Shareholders and Patients

In Deep Track’s View, Properly Focusing on Heplisav Could Result in More than $1 Billion in Cash Generation by 2030 – More than Dynavax’s Current Enterprise Value

Sees Shareholder Representation on Board as Necessary to Restore Investor Confidence in Dynavax and Prevent Strategic Blunders

Urges Shareholders to Vote FOR Deep Track’s Four Highly Qualified Director Nominees

GREENWICH, Conn.--(BUSINESS WIRE)-- Deep Track Capital, LP, (together with its affiliates, “Deep Track” or “we”), one of the largest shareholders

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders

Mon, 21 Apr 2025 16:05:00 -0400

Believes Company’s Misguided Acquisition Strategy is Destroying Value and Preventing Dynavax from Maximizing the Opportunities of Heplisav for Shareholders and Patients

In Deep Track’s View, Properly Focusing on Heplisav Could Result in More than $1 Billion in Cash Generation by 2030 – More than Dynavax’s Current Enterprise Value

Sees Shareholder Representation on Board as Necessary to Restore Investor Confidence in Dynavax and Prevent Strategic Blunders

Urges Shareholders to Vote FOR Deep Track’s Four Highly Qualified Director Nominees

GREENWICH, Conn.--(BUSINESS WIRE)-- Deep Track Capital, LP, (together with its affiliates, “Deep Track” or “we”), one of the largest shareholders

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders

Mon, 21 Apr 2025 16:05:00 -0400

Believes Company’s Misguided Acquisition Strategy is Destroying Value and Preventing Dynavax from Maximizing the Opportunities of Heplisav for Shareholders and Patients

In Deep Track’s View, Properly Focusing on Heplisav Could Result in More than $1 Billion in Cash Generation by 2030 – More than Dynavax’s Current Enterprise Value

Sees Shareholder Representation on Board as Necessary to Restore Investor Confidence in Dynavax and Prevent Strategic Blunders

Urges Shareholders to Vote FOR Deep Track’s Four Highly Qualified Director Nominees

GREENWICH, Conn.--(BUSINESS WIRE)-- Deep Track Capital, LP, (together with its affiliates, “Deep Track” or “we”), one of the largest shareholders